- Home
- TRMD vs RXRX Comparison
TRMD vs RXRX Comparison
Compare TRMD & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRMD | RXRX |
|---|---|---|
| Founded | 1889 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | TRMD | RXRX |
|---|---|---|
| Price | $21.17 | $4.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $23.00 | $7.25 |
| AVG Volume (30 Days) | 590.6K | ★ 28.7M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 9.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.76 | N/A |
| Revenue | ★ $1,292,300,000.00 | $43,689,000.00 |
| Revenue This Year | N/A | $7.79 |
| Revenue Next Year | N/A | $27.32 |
| P/E Ratio | $7.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.60 | $3.79 |
| 52 Week High | $23.67 | $12.36 |
Technical Indicators
Market Signals| Indicator | TRMD | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.33 | 43.50 |
| Support Level | $20.90 | $3.81 |
| Resistance Level | $21.56 | $4.59 |
| Average True Range (ATR) | 0.52 | 0.27 |
| MACD | -0.24 | 0.05 |
| Stochastic Oscillator | 14.48 | 58.08 |
Price Performance
Historical ComparisonAbout TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.